Nu Skin Enterprises Management

Management Kriterienprüfungen 2/4

Nu Skin Enterprises CEO ist Ryan Napierski , ernannt in Mar 2017, hat eine Amtszeit von 7.67 Jahren. Die jährliche Gesamtvergütung beträgt $5.84M , bestehend aus 17% Gehalt und 83% Boni, einschließlich Aktien und Optionen des Unternehmens. besitzt direkt 0.21% der Aktien des Unternehmens, im Wert von $790.91K . Die durchschnittliche Betriebszugehörigkeit des Managementteams und des Verwaltungsrats beträgt 12.1 Jahre bzw. 12.1 Jahre.

Wichtige Informationen

Ryan Napierski

Geschäftsführender

US$5.8m

Gesamtvergütung

Prozentsatz des Geschäftsführergehalts17.0%
Amtszeit als Geschäftsführer7.7yrs
Eigentum des Geschäftsführers0.2%
Durchschnittliche Amtszeit des Managements12.1yrs
Durchschnittliche Amtszeit der Vorstandsmitglieder12.1yrs

Jüngste Management Updates

Nu Skin Enterprises, Inc.'s (NYSE:NUS) CEO Might Not Expect Shareholders To Be So Generous This Year

May 30
Nu Skin Enterprises, Inc.'s (NYSE:NUS) CEO Might Not Expect Shareholders To Be So Generous This Year

Recent updates

Does Nu Skin Enterprises (NYSE:NUS) Have A Healthy Balance Sheet?

Nov 12
Does Nu Skin Enterprises (NYSE:NUS) Have A Healthy Balance Sheet?

Nu Skin: New Products And Ongoing Digital Transformation Imply Undervaluation

Nov 12

The Market Doesn't Like What It Sees From Nu Skin Enterprises, Inc.'s (NYSE:NUS) Revenues Yet As Shares Tumble 27%

Oct 04
The Market Doesn't Like What It Sees From Nu Skin Enterprises, Inc.'s (NYSE:NUS) Revenues Yet As Shares Tumble 27%

Nu Skin Enterprises' (NYSE:NUS) Returns On Capital Not Reflecting Well On The Business

Aug 31
Nu Skin Enterprises' (NYSE:NUS) Returns On Capital Not Reflecting Well On The Business

Insufficient Growth At Nu Skin Enterprises, Inc. (NYSE:NUS) Hampers Share Price

Aug 13
Insufficient Growth At Nu Skin Enterprises, Inc. (NYSE:NUS) Hampers Share Price

Nu Skin Enterprises, Inc.'s (NYSE:NUS) CEO Might Not Expect Shareholders To Be So Generous This Year

May 30
Nu Skin Enterprises, Inc.'s (NYSE:NUS) CEO Might Not Expect Shareholders To Be So Generous This Year

Is Nu Skin Enterprises (NYSE:NUS) Using Too Much Debt?

May 13
Is Nu Skin Enterprises (NYSE:NUS) Using Too Much Debt?

Capital Allocation Trends At Nu Skin Enterprises (NYSE:NUS) Aren't Ideal

Mar 28
Capital Allocation Trends At Nu Skin Enterprises (NYSE:NUS) Aren't Ideal

Nu Skin: A Sell Signal Amidst Industry Decline And Strategic Uncertainty

Mar 04

We Think You Can Look Beyond Nu Skin Enterprises' (NYSE:NUS) Lackluster Earnings

Feb 22
We Think You Can Look Beyond Nu Skin Enterprises' (NYSE:NUS) Lackluster Earnings

Nu Skin Enterprises' (NYSE:NUS) Dividend Will Be Reduced To $0.06

Feb 19
Nu Skin Enterprises' (NYSE:NUS) Dividend Will Be Reduced To $0.06

Analysts Just Shaved Their Nu Skin Enterprises, Inc. (NYSE:NUS) Forecasts Dramatically

Feb 18
Analysts Just Shaved Their Nu Skin Enterprises, Inc. (NYSE:NUS) Forecasts Dramatically

Nu Skin Enterprises, Inc. (NYSE:NUS) Could Be Riskier Than It Looks

Jan 18
Nu Skin Enterprises, Inc. (NYSE:NUS) Could Be Riskier Than It Looks

Nu Skin Enterprises (NYSE:NUS) Has A Somewhat Strained Balance Sheet

Dec 14
Nu Skin Enterprises (NYSE:NUS) Has A Somewhat Strained Balance Sheet

Nu Skin Enterprises (NYSE:NUS) Has Affirmed Its Dividend Of $0.39

Nov 17
Nu Skin Enterprises (NYSE:NUS) Has Affirmed Its Dividend Of $0.39

Nu Skin: Is It Just A Growth Problem?

Oct 17

Nu Skin Enterprises (NYSE:NUS) Could Be At Risk Of Shrinking As A Company

Oct 09
Nu Skin Enterprises (NYSE:NUS) Could Be At Risk Of Shrinking As A Company

When Should You Buy Nu Skin Enterprises, Inc. (NYSE:NUS)?

Sep 27
When Should You Buy Nu Skin Enterprises, Inc. (NYSE:NUS)?

Nu Skin: Attractive Valuation Trumps Near-Term Risks

Sep 12

Nu Skin Enterprises (NYSE:NUS) Takes On Some Risk With Its Use Of Debt

Sep 08
Nu Skin Enterprises (NYSE:NUS) Takes On Some Risk With Its Use Of Debt

Nu Skin Enterprises (NYSE:NUS) Has Announced A Dividend Of $0.39

Aug 05
Nu Skin Enterprises (NYSE:NUS) Has Announced A Dividend Of $0.39

Is Nu Skin Enterprises, Inc. (NYSE:NUS) Expensive For A Reason? A Look At Its Intrinsic Value

Jul 31
Is Nu Skin Enterprises, Inc. (NYSE:NUS) Expensive For A Reason? A Look At Its Intrinsic Value

Nu Skin: A High-Risk/High-Reward Turnaround Play Worth The Risks

Jun 26

Is Now The Time To Look At Buying Nu Skin Enterprises, Inc. (NYSE:NUS)?

Jun 23
Is Now The Time To Look At Buying Nu Skin Enterprises, Inc. (NYSE:NUS)?

We Think Nu Skin Enterprises (NYSE:NUS) Is Taking Some Risk With Its Debt

May 22
We Think Nu Skin Enterprises (NYSE:NUS) Is Taking Some Risk With Its Debt

Nu Skin Enterprises (NYSE:NUS) Will Pay A Dividend Of $0.39

May 07
Nu Skin Enterprises (NYSE:NUS) Will Pay A Dividend Of $0.39

Nu Skin Enterprises (NYSE:NUS) Could Be Struggling To Allocate Capital

Apr 26
Nu Skin Enterprises (NYSE:NUS) Could Be Struggling To Allocate Capital

Why Nu Skin Enterprises, Inc. (NYSE:NUS) Could Be Worth Watching

Mar 18
Why Nu Skin Enterprises, Inc. (NYSE:NUS) Could Be Worth Watching

Nu Skin Enterprises (NYSE:NUS) Will Pay A Larger Dividend Than Last Year At $0.39

Feb 19
Nu Skin Enterprises (NYSE:NUS) Will Pay A Larger Dividend Than Last Year At $0.39

Nu Skin raises quarterly dividend by 1.3% to $0.39/share

Feb 15

Analyse der Geschäftsführervergütung

Wie hat sich die Vergütung von Ryan Napierski im Vergleich zu den Einnahmen von Nu Skin Enterprises verändert?
DatumGesamtvergütungGehaltUnternehmensgewinne
Sep 30 2024n/an/a

-US$103m

Jun 30 2024n/an/a

-US$148m

Mar 31 2024n/an/a

-US$3m

Dec 31 2023US$6mUS$992k

US$9m

Sep 30 2023n/an/a

US$59m

Jun 30 2023n/an/a

US$70m

Mar 31 2023n/an/a

US$77m

Dec 31 2022US$5mUS$942k

US$105m

Sep 30 2022n/an/a

US$38m

Jun 30 2022n/an/a

US$113m

Mar 31 2022n/an/a

US$139m

Dec 31 2021US$5mUS$801k

US$147m

Sep 30 2021n/an/a

US$230m

Jun 30 2021n/an/a

US$237m

Mar 31 2021n/an/a

US$219m

Dec 31 2020US$4mUS$721k

US$191m

Sep 30 2020n/an/a

US$158m

Jun 30 2020n/an/a

US$146m

Mar 31 2020n/an/a

US$150m

Dec 31 2019US$2mUS$688k

US$174m

Sep 30 2019n/an/a

US$116m

Jun 30 2019n/an/a

US$125m

Mar 31 2019n/an/a

US$129m

Dec 31 2018US$3mUS$621k

US$122m

Sep 30 2018n/an/a

US$158m

Jun 30 2018n/an/a

US$146m

Mar 31 2018n/an/a

US$137m

Dec 31 2017US$3mUS$594k

US$129m

Vergütung im Vergleich zum Markt: RyanDie Gesamtvergütung ($USD5.84M) liegt über dem Durchschnitt von Unternehmen ähnlicher Größe auf dem Markt US ($USD2.18M).

Entschädigung vs. Einkommen: RyanDie Bezüge der Mitarbeiter sind gestiegen, während das Unternehmen unrentabel ist.


Geschäftsführer

Ryan Napierski (50 yo)

7.7yrs

Amtszeit

US$5,838,579

Vergütung

Mr. Ryan S. Napierski has been Chief Executive Officer of Nu Skin Enterprises Inc. since September 1, 2021. Mr. Napierski has been the President of Nu Skin Enterprises Inc. since March 7, 2017 and has been...


Führungsteam

NamePositionAmtszeitVergütungEigentümerschaft
Steven Lund
Co-Founder & Executive Chairman of the Board28.8yrsUS$856.61k0.24%
$ 904.8k
Ryan Napierski
President7.7yrsUS$5.84m0.21%
$ 790.9k
James Thomas
Executive VP5.3yrsUS$1.86m0.14%
$ 546.5k
Joseph Chang
Executive VP & Chief Scientific Officer18.8yrsUS$1.12m0.19%
$ 701.6k
Chayce Clark
Executive VP & General Counsel3.3yrsUS$2.28m0.32%
$ 1.2m
Steve Hatchett
Executive VP & Chief Product Officer6.8yrsUS$1.41m0.19%
$ 729.7k
Blake Roney
Founder40.8yrsUS$621.69kkeine Daten
Sandra Tillotson
Founder28.8yrsUS$1.06mkeine Daten
Joe Sueper
Senior VP & CTO3.8yrskeine Datenkeine Daten
Mark Adams
Chief Information Officer18.8yrskeine Datenkeine Daten
Scott Pond
Vice President of Investor Relationsno datakeine Datenkeine Daten
Ashok Pahwa
Chief Marketing Officer16.5yrskeine Datenkeine Daten

12.1yrs

Durchschnittliche Betriebszugehörigkeit

66yo

Durchschnittliches Alter

Erfahrenes Management: NUSDas Führungsteam des Unternehmens verfügt über eine langjährige Erfahrung (12.1 ).


Vorstandsmitglieder

NamePositionAmtszeitVergütungEigentümerschaft
Steven Lund
Co-Founder & Executive Chairman of the Board28.8yrsUS$856.61k0.24%
$ 904.8k
Ryan Napierski
President3.4yrsUS$5.84m0.21%
$ 790.9k
Edwina Woodbury
Independent Director9.4yrsUS$273.20k0.033%
$ 124.9k
Daniel Campbell
Lead Independent Director27.7yrsUS$280.20k0.21%
$ 802.3k
Lars Bohlin
Member of Anti-Aging Scientific Advisory Boardno datakeine Datenkeine Daten
Thomas Pisano
Independent Director16.4yrsUS$257.08k0.15%
$ 547.8k
Zoe Draelos
Member of the Anti-Aging Scientific Advisory Board14.8yrskeine Datenkeine Daten
Paul Cox
Member of Anti-Aging Scientific Advisory Boardno datakeine Datenkeine Daten
Tomas Prolla
Member of Anti-aging Scientific Advisory Board15.1yrskeine Datenkeine Daten
Zheqing Shen
Director8.3yrsUS$249.20k0.044%
$ 165.9k
Laura Nathanson
Independent Director5.4yrsUS$268.20k0.044%
$ 164.2k
Emma Battle
Independent Director3.4yrsUS$264.33k0.039%
$ 145.9k

12.1yrs

Durchschnittliche Betriebszugehörigkeit

67.5yo

Durchschnittliches Alter

Erfahrener Vorstand: NUSDie Vorstandsmitglieder sind sehr erfahren ( 12.1 ).